Tobias Bartscht
Ratzeburger Allee 160
Luebeck, SH 23562, Germany
Luebeck, SH 23562, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Assessment of Physical Activity During Chemotherapy and/or Immunotherapy for Non-Small Cell Lung Cancer (NSCLC): Protocol of the APACHIE-01 Study.
Journal: Clinics and practice
Published: May 28, 2025
Associations Between Chemotherapy-Induced Peripheral Neuropathy and Distress in Patients Assigned to Adjuvant Irradiation for Non-Metastatic Breast Cancer.
Journal: Journal of personalized medicine
Published: April 30, 2025
Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer.
Journal: Anticancer research
Published: March 25, 2025
Chemotherapy-induced Moderate to Severe Peripheral Neuropathy in Patients Receiving Adjuvant Radiotherapy for Breast Cancer.
Journal: Anticancer research
Published: March 11, 2025
Evaluation of Reminder App for Optimization of Bladder Filling Status During Hypo-Fractionated Irradiation for Prostate Cancer: Protocol of REFILL-PAC-HYPO Trial.
Journal: Clinics and practice
Published: January 23, 2025
Development of a Scoring Instrument for Identification of Pneumonitis in Older Lung Cancer Patients After Radiotherapy (POLCAR): A Protocol for a Prospective Trial.
Journal: Cancers
Published: January 16, 2025
A Reminder App to Optimize Bladder Filling During Radiotherapy for Patients With Prostate Cancer (REFILL-PAC): Protocol for a Prospective Trial.
Journal: JMIR research protocols
Published: October 30, 2024
Associations Between Mean Lung Dose and Prevalence of Radiation Pneumonitis in Elderly Lung Cancer Patients.
Journal: Anticancer research
Published: February 14, 2024
Clinically Significant Dermatitis During Adjuvant Radiotherapy for Invasive Breast Cancer.
Journal: Anticancer research
Published: February 07, 2024
Emotional Distress Prior to Chemoradiation for Rectal or Anal Cancer.
Journal: In vivo (Athens, Greece)
Published: February 20, 2023
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Journal: Annals of hematology
Published: October 15, 2022
Last Updated: 09/26/2026